Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 2212-2215

  Smith, Mark A ^a   Hirai, Keisuke ^a   Hsiao, Karen ^b   Pappolla, Miguel A ^c   Harris, Peggy L R ^a   Siedlak, Sandra L ^a   Tabaton, Massimo ^d   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Alzhelmer's disease; Oxidative stress; Transgenic mouse

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031981072     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70052212.x     Document Type: Article

References (26)

1. Baynes J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
2. Behl C., Davis J., Cole G. M., and Schubert D. (1992) Vitamin E protects nerve cells from amyloid-β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
3. Furuta A., Price D. L., Pardo C. A., Troncoso J. C., Xu Z. S., Taniguchi N., and Martin L. J. (1995) Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 146, 357-367.
4. Good P. F., Werner P., Hsu A., Olanow C. W., and Perl D. P. (1996) Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149, 21-28.
5. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
6. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
7. Kim K. S., Miller D. L., Sapienza V. J., Chen C. M. J., Bai C., Grundke-Iqbal I., Currie J. R., and Wisniewski, H. M. (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
8. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O. Jr., Graham D. G., and Montine T. J. (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150, 437-443.
9. Pappolla M. A., Omar R. A., Kim K. S., and Robakis N. K. (1992) Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am. J. Pathol. 140, 621-628.
10. Perry G., Lipphardt S., Mulvihill P., Kancherla M., Mijares M., Gambetti P., Sharma S., Maggiora L., Cornette J., Lobl T., and Greenberg B. (1988) Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet 2, 746.
11. Perry G., Kawai M., Tabaton M., Onorato M., Mulvihill P., Richey P., Morandi A., Connolly J. A., and Gambetti P. (1991) Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J. Neurosci. 11, 1748-1755.
12. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E., Schneider L. S., and Thal L. J. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336, 1216-1222.
13. Sayre L. M., Sha W., Xu G., Kaur K., Nadkarni D., Subbanagounder G., and Salomon R. G. (1996) Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 9, 1194-1201.
14. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., and Smith M. A. (1997a) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
15. Sayre L. M., Zagorski M. G., Surewicz W. K., Krafft G. A., and Perry G. (1997b) Mechanisms of neurotoxicity associated with amyloid β deposition and the role of free radicals in the pathogenesis of Alzheimer's disease. A critical appraisal. Chem. Res. Toxicol. 10, 518-526.
16. Schipper H. M., Cisse S., and Stopa E. G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758-768.
17. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
18. Smith M. A., Richey P. L., Taneda S., Kutty R. K., Sayre L. M., Monnier V. M., and Perry G. (1994a) Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann. NY Acad. Sci. 738, 447-454.
19. Smith M. A., Kutty R. K., Richey P. L., Yan S.-D., Stern D., Chader G. J., Wiggert B., Petersen R. B., and Perry G. (1994b) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am. J. Pathol. 145, 42-47.
20. Smith M. A., Sayre L. M., Monnier V. M., and Perry G. (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci. 18, 172-176.
21. Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F., and Kowall N. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
22. Smith M. A., Harris P. L. R., Sayre L. M., Beckman J. S., and Perry G. (1997a) Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17, 2653-2657.
23. Smith M. A., Harris P. L. R., Sayre L. M., and Perry G. (1997b) Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals. Proc. Natl. Acad. Sci. USA 94, 9866-9868.
24. Sternberger L. A. and Sternberger N. H. (1983) Monoclonal anti-bodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA 80, 6126-6130.
25. Yan S. D., Yan S. F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M. A., Perry G., Godman G. C., Nawroth P., Zweier J. L., and Stern D. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1, 693-699.
26. 2-induced apoptosis in human neuronal cells. Biochem. Biophys. Res. Commun. 235, 845-848.